nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension
|
Shafran, Inbal |
|
|
12 |
6 |
p. 1089-1097 |
artikel |
2 |
Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension
|
Thenappan, Thenappan |
|
|
12 |
6 |
p. 1098-1100 |
artikel |
3 |
Correction
|
|
|
|
12 |
6 |
p. 1136-1140 |
artikel |
4 |
From Mechanisms to Phenotypes
|
Vest, Amanda R. |
|
|
12 |
6 |
p. 1012-1014 |
artikel |
5 |
Full issue PDF
|
|
|
|
12 |
6 |
p. e1-e168 |
artikel |
6 |
Hard Work and Talent in the Battle Against Heart Failure ∗
|
Baran, David A. |
|
|
12 |
6 |
p. 1071-1072 |
artikel |
7 |
Heart Failure With Preserved Ejection Fraction in Patients With Atrial Fibrillation
|
Zakeri, Rosita |
|
|
12 |
6 |
p. 1026-1029 |
artikel |
8 |
Illuminating a Hidden Risk
|
Ammirati, Enrico |
|
|
12 |
6 |
p. 1112-1114 |
artikel |
9 |
Medicare’s Canopy to the Roots of Heart Failure Management
|
Echols, Melvin R. |
|
|
12 |
6 |
p. 1056-1058 |
artikel |
10 |
Middle-Aged Children With Heart Failure
|
Guglin, Maya |
|
|
12 |
6 |
p. 1134 |
artikel |
11 |
National Trends in Hospital Performance in Guideline-Recommended Pharmacologic Treatment for Heart Failure at Discharge
|
Hess, Paul L. |
|
|
12 |
6 |
p. 1059-1070 |
artikel |
12 |
Palliative Care Across the Spectrum of Heart Failure
|
Gelfman, Laura P. |
|
|
12 |
6 |
p. 973-989 |
artikel |
13 |
Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
|
Mentias, Amgad |
|
|
12 |
6 |
p. 1044-1055 |
artikel |
14 |
Pre-Heart Failure, Heart Stress, and Subclinical Heart Failure
|
Bayes-Genis, Antoni |
|
|
12 |
6 |
p. 1115-1118 |
artikel |
15 |
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis
|
Monda, Emanuele |
|
|
12 |
6 |
p. 1101-1111 |
artikel |
16 |
Pulse Pressure Response to Inotrope Therapy in Cardiogenic Shock
|
Han, Jiho |
|
|
12 |
6 |
p. 1126-1127 |
artikel |
17 |
Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten
|
Reza, Nosheen |
|
|
12 |
6 |
p. 1123-1125 |
artikel |
18 |
Reply
|
Yang, Fen |
|
|
12 |
6 |
p. 1135 |
artikel |
19 |
Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF
|
Reddy, Yogesh N.V. |
|
|
12 |
6 |
p. 990-998 |
artikel |
20 |
Serum Markers of Neurodegeneration Are Strongly Linked to Heart Failure Severity and Outcome
|
Wurm, Raphael |
|
|
12 |
6 |
p. 1073-1085 |
artikel |
21 |
Sex Differences in Heart Failure With Improved Ejection Fraction
|
Pabón, Maria A. |
|
|
12 |
6 |
p. 1119-1122 |
artikel |
22 |
Smartphone-Based Recognition of Heart Failure by Means of Microelectromechanical Sensors
|
Haddad, Francois |
|
|
12 |
6 |
p. 1030-1040 |
artikel |
23 |
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction
|
Selvaraj, Senthil |
|
|
12 |
6 |
p. 999-1011 |
artikel |
24 |
The Link Between Heart Failure and Neurodegeneration
|
Traub, Jan |
|
|
12 |
6 |
p. 1086-1088 |
artikel |
25 |
The Year in Review in Heart Failure
|
Bozkurt, Biykem |
|
|
12 |
6 |
p. 1128-1133 |
artikel |
26 |
Use of Digital Devices in Patients With Heart Failure ∗
|
Kose, Orhun |
|
|
12 |
6 |
p. 1041-1043 |
artikel |
27 |
Utility and Validity of the HFA-PEFF and H2FPEF Scores in Patients With Symptomatic Atrial Fibrillation
|
Ariyaratnam, Jonathan P. |
|
|
12 |
6 |
p. 1015-1025 |
artikel |